Showing results (351-360 of 378) with videos related to

Sort By:
Pageof 38
Leukemia|September 3, 2010
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working GroupE Terpos, M A Dimopoulos, O Sezer, et al.
Blood Cancer Journal|June 17, 2017
Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomibE Kastritis, M Gavriatopoulou, M Roussou, et al.
The New England Journal of Medicine|February 22, 1996
Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study GroupJ R Berenson, A Lichtenstein, L Porter, et al.
Leukemia|February 5, 2011
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statementM A Dimopoulos, A Palumbo, M Attal, et al.
Leukemia|February 6, 2014
Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myelomaM A Dimopoulos, X Leleu, A Palumbo, et al.
British Journal of Cancer|November 6, 2008
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) studyA K Koutras, K T Kalogeras, M-A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)A Bamias, U Dafni, A Karadimou, et al.
Breast Cancer Research and Treatment|May 17, 2008
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group studyG Fountzilas, U Dafni, M A Dimopoulos, et al.
Blood Cancer Journal|April 22, 2017
Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatmentM A Dimopoulos, A K Stewart, T Masszi, et al.
Blood Cancer Journal|August 26, 2017
Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working GroupJ Hillengass, L A Moulopoulos, S Delorme, et al.
Pageof 38